rss
J Clin Pathol doi:10.1136/jcp.2007.054262

High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma

  1. Hedy Vekony (h.vekony{at}vumc.nl)
  1. Academic Centre for Dentistry (ACTA), VU University Medical Center (VUmc), Amsterdam, Netherlands
    1. Frank M Raaphorst (frank.raaphorst{at}biofarmind.nl)
    1. Biofarmind, The Hague, Netherlands
      1. Arie P Otte (arieotte{at}science.uva.nl)
      1. Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, Netherlands
        1. Maarten Van Lohuizen (m.v.lohuizen{at}nki.nl)
        1. Netherlands Cancer Institute, Amsterdam, Netherlands
          1. C. Rene Leemans (cr.leemans{at}vumc.nl)
          1. VU University Medical Center (VUmc), Amsterdam, Netherlands
            1. Isaac Van der Waal (i.vanderwaal{at}vumc.nl)
            1. Academic Centre for Dentistry (ACTA), VU University Medical Center (VUmc), Amsterdam, Netherlands
              1. Elisabeth Bloemena (e.bloemena{at}vumc.nl)
              1. Academic Centre for Dentistry (ACTA), VU University Medical Center, Netherlands
                • Published Online First 6 March 2008

                Abstract

                Background: Prognosis of adenoid cystic carcinoma (ACC), a malignant salivary gland tumor, depends on clinicopathological parameters. To decipher ACC’s biological behavior and to identify patients at risk of developing metastases, additional markers are needed.

                Methods: We investigated immunohistochemically the expression of the cell cycle proteins p53, Cyclin D1, p16INK4a, E2F1 and Ki-67, together with the Polycomb group (PcG) proteins BMI-1, MEL-18, EZH2, and EED in 21 formalin-fixed, paraffin-embedded primary ACCs in relation to tumor characteristics.

                Results: ACC reveals significantly increased expression of the cell cycle proteins compared to normal salivary tissue (n=17). Members of the two PcG complexes display mutually exclusive expression in normal salivary gland tissue, with BMI-1 and MEL-18 being abundantly present. In ACC, this expression pattern is disturbed, with EZH2 and EED showing significantly increased expression levels. In univariate analysis, presence of recurrence, poor differentiation, and high EZH2 levels (>25% immunopositivity) significantly correlate with unfavorable outcome. ACCs with high proliferative rate (>25% Ki-67 immunopositivity) significantly correlate with high levels of EZH2 and p16. Only the development of recurrence was an independent prognostic factor of survival in multivariate analysis.

                Conclusions: Expression of PcG complexes and of essential cell cycle proteins is highly deregulated in ACC. Also, EZH2 expression has prognostic relevance in this malignancy.

                This Article

                1. Abstract
                2. PDF
                3. All versions of this article:
                  1. jcp.2007.054262v1
                  2. jcp.2007.054262v2
                  3. 61/6/744most recent

                Responses

                1. Submit a response
                2. No responses published

                Register for free content


                Free trial
                Individuals may register for a free 60 day online trial to all content.

                Free archive
                The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

                Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar